These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2570962)

  • 1. Drugs acting on 5-hydroxytryptamine receptors.
    Lancet; 1989 Sep; 2(8665):717-9. PubMed ID: 2570962
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonin receptor subtypes and neuropsychiatric diseases: focus on 5-HT1D and 5-HT3 receptor agents.
    Peroutka SJ
    Pharmacol Rev; 1991 Dec; 43(4):579-86. PubMed ID: 1663621
    [No Abstract]   [Full Text] [Related]  

  • 3. Serotonin receptors and therapeutics.
    Launay JM; Callebert J; Bondoux D; Loric S; Maroteaux L
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):327-36. PubMed ID: 7522716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The world of serotonin and its receptors. Physiopathologic, clinical, and therapeutic aspects].
    Marco Igual M
    Med Clin (Barc); 1993 Jun; 101(4):144-53. PubMed ID: 8355545
    [No Abstract]   [Full Text] [Related]  

  • 5. 5HT3-antagonist receptors: their role in drug-induced emesis.
    Dieras V; Extra JM; Le Bonniec M; Madelaine I; Espie M; Marty M
    Nouv Rev Fr Hematol (1978); 1990; 32(6):449-52. PubMed ID: 1983228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonists and antagonists of 5-hydroxytryptamine on venomotor receptors.
    Aellig WH
    Adv Neurol; 1982; 33():321-4. PubMed ID: 7055012
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tropoxin--a new serotonin antagonist and potential antimigraine agent].
    Mirzoian RS; Seredenin SB; Gan'shina TS; Kostochka LM; Romanycheva NA; Rusakov DIu
    Eksp Klin Farmakol; 1998; 61(3):28-31. PubMed ID: 9690072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurotransmitter mechanism of the tropoxin effect in comparison with other antimigraine preparations].
    Gan'shina TS
    Eksp Klin Farmakol; 2003; 66(3):17-20. PubMed ID: 12924226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacology and clinical experiences with serotonin (5-HT3) receptor antagonists].
    Scholz J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Oct; 32(10):626-8. PubMed ID: 9445561
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism.
    Miner WD; Sanger GJ
    Br J Pharmacol; 1986 Jul; 88(3):497-9. PubMed ID: 3742146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic mechanisms of antimigraine drugs.
    Fozard JR
    Adv Neurol; 1982; 33():295-307. PubMed ID: 7034488
    [No Abstract]   [Full Text] [Related]  

  • 12. Are vascular mechanisms involved in antidepressant action?
    DeFeudis FV
    Gen Pharmacol; 1985; 16(6):553-6. PubMed ID: 3910516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of 5-hydroxytryptamine receptors in the gut.
    Read NW; Gwee KA
    Pharmacol Ther; 1994; 62(1-2):159-73. PubMed ID: 7991641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interval therapy of migraine. Pharmacological bases].
    Ziegler A
    Fortschr Med; 1984 Mar; 102(12):328-32. PubMed ID: 6143715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New therapeutic possibilities with drugs affecting serotonin receptors].
    Spigset O
    Tidsskr Nor Laegeforen; 1992 May; 112(13):1700-4. PubMed ID: 1509427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of 5-HT1A and 5-HT2 receptor in cisplatin induced emesis in dogs.
    Gupta YK; Sharma SS
    Indian J Physiol Pharmacol; 2002 Oct; 46(4):463-7. PubMed ID: 12683222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of serotonin and serotonin receptors in the pathogenesis of migraine and in the mechanisms of action of anti-migraine drugs].
    Amelin AV; Skoromets AA; Ignatov IuD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(7):55-8. PubMed ID: 10957805
    [No Abstract]   [Full Text] [Related]  

  • 18. Importance of headache.
    Peatfield RC
    Curr Med Res Opin; 2001; 17 Suppl 1():s1-3. PubMed ID: 12463269
    [No Abstract]   [Full Text] [Related]  

  • 19. [Type-3 serotonin receptor blockaders (5-HT3)--a new class of antiemetic preparations].
    Legeza VI
    Eksp Klin Farmakol; 1994; 57(4):72-5. PubMed ID: 7950795
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects on arterial receptors of ergot derivatives used in migraine.
    Müller-Schweinitzer E; Fanchamps A
    Adv Neurol; 1982; 33():343-56. PubMed ID: 6275676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.